Home/Emanate Biomedical/Dr. Jacques Seguin

DJ

Dr. Jacques Seguin

Chairman

Emanate Biomedical

Therapeutic Areas

Periodontal Disease Oral Wounds Oral Mucositis

Emanate Biomedical Pipeline

Drug	Indication	Phase
PODS™ Platform	Oral Diseases and Wounds (e.g., Periodontitis, Oral Mucositis)	Pre-clinical/Clinical Development

Leadership Team at Emanate Biomedical

Founder and CEO

Dr. Peter Zegarelli

Co-Founder and Chief Clinical Officer

Dorna Hakimi, PhD

Chief Technology Officer

Chief Medical Officer

View full Emanate Biomedical profile